BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
EMPLOYEES: 200 employees
HISTORY: Formed from the consolidation of The Center for the Advancement of
Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA)
and the J. Craig Venter Science Foundation Joint Technology Center (JTC)
(9/04)
Member--Biotechnology Industry Organization
FACILITIES: Joint Technology Center--60,000 sq. ft.
5 Research Place
Rockville, MD 20850
Phone: (240) 243-1500
Fax: (240) 243-0600
STOCK-FINANCIAL HISTORY: Nonprofit research institute
BUSINESS STRATEGY: The J. Craig Venter Institute is dedicated to the advancement of the science
of genomics, understanding its implications for society, and communicating
those results to the scientific community, public and policymakers.
RESEARCH & DEVELOPMENT: Genomic medicine with an emphasis on cancer genomics and human
genome resequencing and analysis
Environmental genomic analysis with an emphasis on microbial biodiversity,
ecology and evolution
Use of molecular and genomic methods to develop biological sources of
clean energy
Synthetic genome development
Policy research on the ethical, legal and economic issues associated with
genomic science and technology
Johnson Matthey Pharma Services
35 Patton Road
Devins MA 01434, US
Phone: (978) 784-5000; Fax: (978) 784-5000
Web: www.jmpharmaservices.com
E-mail: etetreau@jmusa.com
KEY PERSONNEL: Roger Kilburn; Exec. VP and GM
Lee Piver; Sr. Director, Industry Relations
Mike McKinley; Director, Finance and Materials Management
Harwood Stiles; Director, Quality
Paula J. Lorence; Director, Sales and Marketing
Daniel J. Coughlin, Ph.D.; Director, Medicinal Chemistry
Heather Taft, Ph.D.; Director, Chemical Development
Tony Chong, Ph.D.; Director, Chemical Development and Pilot Plant
EMPLOYEES: 150+ employees
HISTORY: Founded in 1972
Began biotech R&D in 1984
Acquired by Johnson Matthey (2001)
Changed name from Pharm-Eco (12/04)
FACILITIES: 50,000 sq. ft. headquarters and R&D facilities
20,000 sq. ft. manufacturing facilities
STOCK-FINANCIAL HISTORY: Privately held--Parent company Johnson Matthey is a public company
SUBSIDIARY OF: Johnson Matthey
BUSINESS STRATEGY: Provide API chemistry services to clients throughout the drug development
process, from early stage discovery services to commercial manufacturing.
Copyright ©2006 AHC Media ® 203